Hundemer M - Search Results

1

T cell-based targeted immunotherapies for patients with multiple myeloma.

Wang L, Jin N, Schmitt A, Greiner J, Malcherek G, Hundemer M, Mani J, Hose D, Raab MS, Ho AD, Chen BA, Goldschmidt H, Schmitt M. Wang L, et al. Among authors: hundemer m. Int J Cancer. 2015 Apr 15;136(8):1751-68. doi: 10.1002/ijc.29190. Epub 2014 Sep 19. Int J Cancer. 2015. PMID: 25195787 Free article. Review.

2

High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.

Perz JB, Schonland SO, Hundemer M, Kristen AV, Dengler TJ, Zeier M, Linke RP, Ho AD, Goldschmidt H. Perz JB, et al. Among authors: hundemer m. Br J Haematol. 2004 Dec;127(5):543-51. doi: 10.1111/j.1365-2141.2004.05232.x. Br J Haematol. 2004. PMID: 15566357 Free article. Clinical Trial.

3

Targeting positive regulatory domain I-binding factor 1 and X box-binding protein 1 transcription factors by multiple myeloma-reactive CTL.

Lotz C, Mutallib SA, Oehlrich N, Liewer U, Ferreira EA, Moos M, Hundemer M, Schneider S, Strand S, Huber C, Goldschmidt H, Theobald M. Lotz C, et al. Among authors: hundemer m. J Immunol. 2005 Jul 15;175(2):1301-9. doi: 10.4049/jimmunol.175.2.1301. J Immunol. 2005. PMID: 16002735

4

Risk stratification in cardiac amyloidosis: novel approaches.

Kristen AV, Meyer FJ, Perz JB, Schonland SO, Hundemer M, Hegenbart U, Singer R, Schnabel PA, Sack FU, Goldschmidt H, Katus HA, Dengler TJ. Kristen AV, et al. Among authors: hundemer m. Transplantation. 2005 Sep 27;80(1 Suppl):S151-5. doi: 10.1097/01.tp.0000187111.00076.1a. Transplantation. 2005. PMID: 16286895 Review.

5

Indications for high-dose chemotherapy with autologous stem cell support in patients with systemic amyloid light chain amyloidosis.

Schonland SO, Perz JB, Hundemer M, Hegenbart U, Kristen AV, Hund E, Dengler TJ, Beimler J, Zeier M, Singer R, Linke RP, Ho AD, Goldschmidt H. Schonland SO, et al. Among authors: hundemer m. Transplantation. 2005 Sep 27;80(1 Suppl):S160-3. doi: 10.1097/01.tp.0000186902.57687.8d. Transplantation. 2005. PMID: 16286897

6

Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.

Hundemer M, Schmidt S, Condomines M, Lupu A, Hose D, Moos M, Cremer F, Kleist C, Terness P, Belle S, Ho AD, Goldschmidt H, Klein B, Christensen O. Hundemer M, et al. Exp Hematol. 2006 Apr;34(4):486-96. doi: 10.1016/j.exphem.2006.01.008. Exp Hematol. 2006. PMID: 16569595 Free PMC article.

7

Identification and characterization of HLA-class-I-restricted T-cell epitopes in the putative tumor-associated antigens P21-activated serin kinase 2 (PAK2) and cyclin-dependent kinase inhibitor 1A (CDKN1A).

Li G, Hundemer M, Wolfrum S, Ho AD, Goldschmidt H, Witzens-Harig M. Li G, et al. Among authors: hundemer m. Ann Hematol. 2006 Sep;85(9):583-90. doi: 10.1007/s00277-006-0137-x. Epub 2006 May 23. Ann Hematol. 2006. PMID: 16718496

8

CD200 is a new prognostic factor in multiple myeloma.

Moreaux J, Hose D, Reme T, Jourdan E, Hundemer M, Legouffe E, Moine P, Bourin P, Moos M, Corre J, Möhler T, De Vos J, Rossi JF, Goldschmidt H, Klein B. Moreaux J, et al. Among authors: hundemer m. Blood. 2006 Dec 15;108(13):4194-7. doi: 10.1182/blood-2006-06-029355. Epub 2006 Aug 31. Blood. 2006. PMID: 16946299 Free article.

9

The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure.

Raab MS, Breitkreutz I, Hundemer M, Benner A, Klaus J, Hegenbart U, Moehler T, Ho AD, Zeier M, Goldschmidt H. Raab MS, et al. Among authors: hundemer m. Haematologica. 2006 Nov;91(11):1555-8. Haematologica. 2006. PMID: 17082013

10

Cancer/testis genes in multiple myeloma: expression patterns and prognosis value determined by microarray analysis.

Condomines M, Hose D, Raynaud P, Hundemer M, De Vos J, Baudard M, Moehler T, Pantesco V, Moos M, Schved JF, Rossi JF, Rème T, Goldschmidt H, Klein B. Condomines M, et al. Among authors: hundemer m. J Immunol. 2007 Mar 1;178(5):3307-15. doi: 10.4049/jimmunol.178.5.3307. J Immunol. 2007. PMID: 17312182 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page